Advertisement

Topics

Non-traditional Collaborations Fuel Biopharma Innovation

11:17 EDT 7 Aug 2017 | BioScience Technology

A major trend that emerged from Deloitte’s research is the life science industry’s shift from traditional asset-based partnerships to collaborative, non-asset-based R&D partnerships.
Contributed Author: 
Michelle Taylor, Editor-in-Chief, Laboratory Equipment
Topics: 

Original Article: Non-traditional Collaborations Fuel Biopharma Innovation

NEXT ARTICLE

More From BioPortfolio on "Non-traditional Collaborations Fuel Biopharma Innovation"

Quick Search
Advertisement
 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.